Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry

Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry

<p>Abstract</p> <p>Background</p> <p>This study is a pre-planned country-specific subanalysis of results in Germany from a multinational multicenter registry to prospectively assess real-world experience with caspofungin administered for treatment of proven or probable...

Full description

Bibliographic Details
Main Authors:	Egerer Gerlinde, Reichert Dietmar, Pletz Mathias W, Kaskel Peter, Krobot Karl J, Maertens Johan
Format:	Article
Language:	English
Published:	BMC 2012-04-01
Series:	European Journal of Medical Research
Subjects:	Invasive fungal disease Invasive aspergillosis Therapy Echinocandins Caspofungin
Online Access:	http://www.eurjmedres.com/content/17/1/7

Similar Items

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
by: Gebremedhin Beedemariam Gebretekle, et al.
Published: (2022-10-01)

Successful management of recalcitrant fungal keratitis with topical caspofungin
by: Goel, Siddhi, et al.
Published: (2022-07-01)

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature
by: Kofla G, et al.
Published: (2011-04-01)

Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis
by: Prépost E, et al.
Published: (2019-07-01)

Caspofungin Cerebral Penetration and Therapeutic Efficacy in Experimental Cerebral Aspergillosis
by: Irina Ullmann, et al.
Published: (2022-06-01)

Caspofungin pharmacokinetics and probability of target attainment in ICU patients in China
by: Fangyi Li, et al.
Published: (2021-06-01)

Antifungal effects of echinocandins diminish when exposed to intestinal lumen contents: a finding with potentially significant clinical implications
by: Sepideh Mehravar, et al.
Published: (2024-03-01)

Clinico-mycological profile of suspected pulmonary aspergillosis cases
by: Bavleen Kaur, et al.
Published: (2023-01-01)

Diagnosis and management of invasive fungal diseases in non-neutropenic ICU patients, with focus on candidiasis and aspergillosis: a comprehensive review
by: Afzal Azim, et al.
Published: (2024-03-01)

Airborne fungal spores and invasive aspergillosis in hematologic units in a tertiary hospital during construction: a prospective cohort study
by: Joung Ha Park, et al.
Published: (2019-05-01)

Efficacy and safety of triazoles versus echinocandins in the treatment of invasive aspergillosis: A meta-analysis
by: Uzelac Sanja M., et al.
Published: (2020-01-01)

Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
by: Gerardo Aguilar, et al.
Published: (2017-01-01)

Identification of Genes in Candida glabrata Conferring Altered Responses to Caspofungin, a Cell Wall Synthesis Inhibitor
by: Anne G. Rosenwald, et al.
Published: (2016-09-01)

Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age
by: Toine Mercier, et al.
Published: (2018-04-01)

INVASIVE MYCOSES IN INTENSIVE CARE UNITS
by: Yakubtsevich R. E.
Published: (2020-03-01)

Treatment Of Invasive Aspergillosis
by: İlknur ERDEM, et al.
Published: (2018-08-01)

Salvage Treatment for Invasive Aspergillosis and Mucormycosis: Challenges, Recommendations and Future Considerations
by: Egger M, et al.
Published: (2023-04-01)

Invasive sino-orbital aspergillosis with brain invasion in an immunocompetent pregnant patient
by: Hamad M. Alsulaiman, et al.
Published: (2021-12-01)

Decoding the Guidelines of Invasive Pulmonary Aspergillosis in Critical Care Setting: Imaging Perspective
by: Anisha Garg, et al.
Published: (2023-07-01)

Novel treatment possibilities of invasive aspergillosis
by: G. A. Klyasova
Published: (2021-11-01)

Evaluation of Bronchoalveolar Lavage Fluid Cytokines as Biomarkers for Invasive Pulmonary Aspergillosis in At-Risk Patients
by: Samuel M. Gonçalves, et al.
Published: (2017-11-01)

Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication
by: Francis Vekeman, et al.
Published: (2018-08-01)

Pacemaker lead Candida endocarditis: Is medical treatment possible?
by: Syamasis Bandyopadhyay, et al.
Published: (2015-12-01)

How Has the Aspergillosis Case Fatality Rate Changed over the Last Two Decades in Spain?
by: Pablo González-García, et al.
Published: (2022-05-01)

Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome
by: Rebecca van Grootveld, et al.
Published: (2023-02-01)

Cerebro-rhino-orbital mucormycosis and aspergillosis coinfection in a patient with diabetes mellitus: A case report
by: Souheil Zayet, et al.
Published: (2021-01-01)

<i>Candida albicans</i> Strains Adapted to Caspofungin Due to Aneuploidy Become Highly Tolerant under Continued Drug Pressure
by: Farha Husain, et al.
Published: (2022-12-01)

Pulmonary Aspergillosis: What CT can Offer Before it is too Late!
by: AKHILA PRASAD, et al.
Published: (2016-04-01)

Invasive Aspergillosis in COVID-19: A Review Study and Recommendations for Diagnostic Approaches
by: Vida Mortezaee, et al.
Published: (2020-05-01)

Caspofungin Use in Daily Clinical Practice for Treatment of Invasive Aspergillosis: Results of a Prospective Observational Registry
by: Chandwani Sheenu, et al.
Published: (2010-06-01)

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence
by: Ethan R. Stewart, et al.
Published: (2016-09-01)

Diagnosis and Treatment of Invasive Aspergillosis Caused by Non-<i>fumigatus Aspergillus</i> spp.
by: Jannik Stemler, et al.
Published: (2023-04-01)

Proteome analysis of bronchoalveolar lavage fluids reveals host and fungal proteins highly expressed during invasive pulmonary aspergillosis in mice and humans
by: Silke Machata, et al.
Published: (2020-12-01)

Challenging Diagnosis of Invasive Sinus Aspergillosis Mimicking Gradenigo’s Syndrome in an Elderly Patient with T-Cell Lymphoma
by: Victoria Ramos de Ascanio, et al.
Published: (2023-12-01)

Absence of clinically relevant effect of caspofungin on cyclosporin pharmacokinetics
by: C Sanz-Rodriguez, et al.
Published: (2005-11-01)

Cerebral aspergillosis and facial acneiform lesions following initiation of ibrutinib in a patient with chronic lymphocytic leukemia
by: Helbies Bedier, et al.
Published: (2021-01-01)

Use of Antifungals and Outcomes Among Inpatients at Risk of Invasive Aspergillosis or Mucormycosis in the USA: A Retrospective Cohort Study
by: Katherine Stull, et al.
Published: (2019-10-01)

Gel Formulations with an Echinocandin for Cutaneous Candidiasis: The Influence of Azone and Transcutol on Biopharmaceutical Features
by: Noelia Pérez-González, et al.
Published: (2023-04-01)

INVASIVE ASPERGILLOSIS IN CHILDREN: UPDATE ON CURRENT GUIDELINES
by: Athanasia Apsemidou, et al.
Published: (2018-09-01)

Pleuropulmonary aspergillosis in an immunocompetent patient presenting as pleural-based peripheral lung mass: A sporadic occurrence
by: P Amal Johnson, et al.
Published: (2021-01-01)